Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI

NCT04149990 is registered in ClinicalTrials.gov with Jacob Moller as lead sponsor.

NCT NCT04149990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04149990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI
Lead sponsor
Jacob Moller
Phase
Phase 2
Overall status
Terminated
Start date
October 12, 2018
Completion date
June 6, 2023
Enrollment
51 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diastolic dysfunction, myocardial infarction